| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Ann Richmond | Q63665124 |
| P2093 | author name string | Yingjun Su | |
| Jinming Yang | |||
| P2860 | cites work | The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma | Q24658422 |
| CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature | Q24681010 | ||
| Cancer-related inflammation | Q27860907 | ||
| Inflammation and cancer: back to Virchow? | Q28036756 | ||
| Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins | Q28251702 | ||
| The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer | Q28259852 | ||
| Control of chemokine-guided cell migration by ligand sequestration | Q28268329 | ||
| Chemokines, chemokine receptors, and cancer metastasis | Q28297436 | ||
| Down-regulation of surface fractalkine by RNA interference in B16 melanoma reduced tumor growth in mice | Q28511518 | ||
| Smoldering and polarized inflammation in the initiation and promotion of malignant disease | Q29618034 | ||
| Chemokines as mediators of angiogenesis. | Q30426904 | ||
| CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease | Q30435000 | ||
| Gene expression profiling reveals cross-talk between melanoma and fibroblasts: implications for host-tumor interactions in metastasis | Q30436849 | ||
| Chemokines as mediators of neovascularization | Q30438032 | ||
| Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth | Q30439835 | ||
| The gene expression signatures of melanoma progression | Q30850724 | ||
| CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. | Q33201297 | ||
| Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry | Q33874221 | ||
| Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis | Q34418159 | ||
| The role of chemokines in melanoma tumor growth and metastasis | Q34680888 | ||
| Role of CXCL1 in tumorigenesis of melanoma. | Q34724089 | ||
| Nf-kappa B, chemokine gene transcription and tumour growth | Q34810265 | ||
| Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses | Q35173629 | ||
| Endogenous IL-12 triggers an antiangiogenic program in melanoma cells. | Q35676753 | ||
| Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis | Q35763932 | ||
| Chemokine receptors and melanoma metastasis | Q35935290 | ||
| CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors | Q35954365 | ||
| CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway | Q36003309 | ||
| Role of chemokines in tumor growth | Q36120825 | ||
| Chemokine blockers--therapeutics in the making? | Q36323784 | ||
| Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases. | Q36432030 | ||
| Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8. | Q36590676 | ||
| The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice. | Q36617478 | ||
| The chemokine and chemokine receptor superfamilies and their molecular evolution | Q36698659 | ||
| "Re-educating" tumor-associated macrophages by targeting NF-kappaB. | Q36699735 | ||
| Organ selectivity in metastasis: regulation by chemokines and their receptors | Q36949936 | ||
| Effects of chemokines on tumor metastasis. | Q36978115 | ||
| Cancer stem cells: implications for the progression and treatment of metastatic disease. | Q37053174 | ||
| Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry | Q37061114 | ||
| The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites | Q37096553 | ||
| Host CXCR2-dependent regulation of melanoma growth, angiogenesis, and experimental lung metastasis | Q37120171 | ||
| Systemic targeting inhibitor of kappaB kinase inhibits melanoma tumor growth | Q37149856 | ||
| Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells | Q37149868 | ||
| The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan | Q37156706 | ||
| How chemokines invite leukocytes to dance | Q37246681 | ||
| Tumor immunotherapy in melanoma: strategies for overcoming mechanisms of resistance and escape | Q37248662 | ||
| Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases | Q37313639 | ||
| Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer | Q37326196 | ||
| Melanoma and innate immunity--aActive inflammation or just erroneous attraction? Melanoma as the source of leukocyte-attracting chemokines. | Q37336165 | ||
| Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine | Q37385045 | ||
| The lymphotoxin-beta receptor is an upstream activator of NF-kappaB-mediated transcription in melanoma cells | Q38631619 | ||
| The chemokine receptor CXCR4 and the metalloproteinase MT1-MMP are mutually required during melanoma metastasis to lungs. | Q39894560 | ||
| The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10. | Q47384264 | ||
| The Duffy antigen/receptor for chemokines (DARC) and prostate cancer. A role as clear as black and white? | Q47907368 | ||
| Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma | Q47951335 | ||
| Three-dimensional culture of melanoma cells profoundly affects gene expression profile: a high density oligonucleotide array study. | Q51593652 | ||
| Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiation. | Q53644294 | ||
| The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristics. | Q54590866 | ||
| Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. | Q54595543 | ||
| Inflaming metastasis | Q56942551 | ||
| Blockade of the Stromal Cell–Derived Factor-1/CXCR4 Axis AttenuatesIn vivoTumor Growth by Inhibiting Angiogenesis in a Vascular Endothelial Growth Factor–Independent Manner | Q57078137 | ||
| MCP-3 (CCL7) delivered by parvovirus MVMp reduces tumorigenicity of mouse melanoma cells through activation of T lymphocytes and NK cells | Q62019442 | ||
| Re: Roddam AW, Duffy MJ, Hamdy FC, et al. Use of Prostate-Specific Antigen (PSA) Isoforms for the Detection of Prostate Cancer in Men with a PSA Level of 2–10ng/ml: Systematic Review and Meta-Analysis. Eur Urol 2005;48:386–99 | Q62632500 | ||
| CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell type | Q63247797 | ||
| Adenoviral gene transfer of stromal cell-derived factor-1 to murine tumors induces the accumulation of dendritic cells and suppresses tumor growth | Q64377921 | ||
| Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells | Q70890742 | ||
| IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor | Q72901004 | ||
| Interleukin‐8 secreted by endothelial cells induces Chemotaxis of melanoma cells through the chemokine receptor CXCR1 | Q73372722 | ||
| Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival | Q73513608 | ||
| Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells | Q74020371 | ||
| Lessons learned from lymphocytes: CC chemokine receptor-7 involved in lymphogenic metastasis of melanoma | Q77137400 | ||
| Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma | Q77137462 | ||
| Role of interleukin-8 in tumor growth and metastasis of human melanoma | Q77748418 | ||
| Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells | Q78710357 | ||
| Chemokine-mediated migration of melanoma cells towards lymphatics--a mechanism contributing to metastasis | Q79387215 | ||
| Delivery of CCL21 to metastatic disease improves the efficacy of adoptive T-cell therapy | Q79518341 | ||
| Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence | Q80489355 | ||
| Differential expression of chemokine receptors on uveal melanoma cells and their metastases | Q80595281 | ||
| CCR9 homes metastatic melanoma cells to the small bowel | Q80620502 | ||
| Overexpression of matrix metalloproteinases, chemokines, and chemokine receptors relevant for metastasis in experimental models not an indication of lymph node metastases in human melanoma | Q80635559 | ||
| Oral and oropharyngeal squamous cell carcinomas expressing CCR7 have poor prognoses | Q81348754 | ||
| Combining SDF-1/CXCR4 antagonism and chemotherapy in relapsed acute myeloid leukemia | Q81612671 | ||
| C-C chemokine receptor 5 on stromal cells promotes pulmonary metastasis | Q81656295 | ||
| Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma | Q82174987 | ||
| Migration of cytotoxic T lymphocytes toward melanoma cells in three-dimensional organotypic culture is dependent on CCL2 and CCR4 | Q82300268 | ||
| Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape | Q83212904 | ||
| The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma | Q39923060 | ||
| Effect of the chemokine receptor CXCR7 on proliferation of carcinoma cells in vitro and in vivo | Q39929406 | ||
| A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion. | Q39931549 | ||
| Interleukin-8 signaling attenuates TRAIL- and chemotherapy-induced apoptosis through transcriptional regulation of c-FLIP in prostate cancer cells | Q39940173 | ||
| A novel B-RAF inhibitor blocks interleukin-8 (IL-8) synthesis in human melanoma xenografts, revealing IL-8 as a potential pharmacodynamic biomarker | Q40001486 | ||
| Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice | Q40054621 | ||
| Recombined CC chemokine ligand 2 into B16 cells induces production of Th2-dominant [correction of dominanted] cytokines and inhibits melanoma metastasis | Q40080409 | ||
| Tumor-derived chemokine MCP-1/CCL2 is sufficient for mediating tumor tropism of adoptively transferred T cells. | Q40091300 | ||
| Ultraviolet-B irradiation enhances melanoma cell motility via induction of autocrine interleukin 8 secretion | Q40109624 | ||
| Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis. | Q40118445 | ||
| Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist | Q40134007 | ||
| Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft | Q40140782 | ||
| Profiles of chemokine receptors in melanocytic lesions: de novo expression of CXCR6 in melanoma | Q40170184 | ||
| Regulation of interleukin-8 expression in melanoma-stimulated neutrophil inflammatory response. | Q40201937 | ||
| Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion | Q40213967 | ||
| Preferential involvement of CX chemokine receptor 4 and CX chemokine ligand 12 in T-cell migration toward melanoma cells. | Q40240200 | ||
| Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients | Q40283597 | ||
| CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma. | Q40288412 | ||
| Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis | Q40291696 | ||
| A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer | Q40304146 | ||
| BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: involvement of nuclear factor kappaB and mitochondria pathways | Q40318894 | ||
| The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth | Q40333696 | ||
| Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant. | Q40383031 | ||
| CXC chemokine ligand 12 (stromal cell-derived factor 1 alpha) and CXCR4-dependent migration of CTLs toward melanoma cells in organotypic culture | Q40432536 | ||
| A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanoma | Q40543358 | ||
| IL-12 pretreatments enhance IFN-alpha-induced Janus kinase-STAT signaling and potentiate the antitumor effects of IFN-alpha in a murine model of malignant melanoma | Q40547466 | ||
| Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes | Q40550111 | ||
| Methylation of polycomb target genes in intestinal cancer is mediated by inflammation | Q41203475 | ||
| Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression | Q41640097 | ||
| Effects of MGSA/GRO alpha on melanocyte transformation | Q41676895 | ||
| Expression of monocyte chemotactic protein-1 in human melanoma in vivo | Q42280724 | ||
| The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis | Q42411644 | ||
| Chemokine markers predict biochemical recurrence of prostate cancer following prostatectomy | Q42660306 | ||
| A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth | Q42820599 | ||
| Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma | Q43641561 | ||
| Induction of melanoma in murine macrophage inflammatory protein 2 transgenic mice heterozygous for inhibitor of kinase/alternate reading frame. | Q43806546 | ||
| Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy | Q44319954 | ||
| Transcriptional profiling of targets for combination therapy of lung carcinoma with paclitaxel and mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor | Q44564131 | ||
| CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin | Q44635459 | ||
| Optimization of antitumor efficacy and safety of in vivo cytokine gene therapy using RGD fiber-mutant adenovirus vector for preexisting murine melanoma | Q44774220 | ||
| Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity | Q45876491 | ||
| Induction of haptotactic migration of melanoma cells by neutrophil activating protein/interleukin-8. | Q46521422 | ||
| Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC). | Q46757098 | ||
| Decline in angiogenic factors, such as interleukin-8, indicates response to chemotherapy of metastatic melanoma | Q46825243 | ||
| Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interleukin-8 (CXCL-8)-mediated modulation of metastatic phenotype | Q47276398 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 175-186 | |
| P577 | publication date | 2009-02-14 | |
| P1433 | published in | Pigment Cell & Melanoma Research | Q762851 |
| P1476 | title | The good and the bad of chemokines/chemokine receptors in melanoma | |
| P478 | volume | 22 |
| Q38909630 | Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonists |
| Q83966053 | CCL27-CCR10 and CXCL12-CXCR4 chemokine ligand-receptor mRNA expression ratio: new predictive factors of tumor progression in cutaneous malignant melanoma |
| Q39223523 | CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma |
| Q64941714 | CCR9:CCL25 in melanoma metastatic to small intestine. |
| Q37658774 | CXCL8 and its cognate receptors in melanoma progression and metastasis |
| Q45124603 | CXCR7 mediates SDF1-induced melanocyte migration |
| Q64104116 | CXCR7 promotes melanoma tumorigenesis via Src kinase signaling |
| Q38403945 | Chemokines in the melanoma metastasis biomarkers portrait. |
| Q35092571 | Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth |
| Q44759315 | Circulating CLA+ T lymphocytes as peripheral cell biomarkers in T-cell-mediated skin diseases |
| Q39770376 | Combination of dacarbazine and dimethylfumarate efficiently reduces melanoma lymph node metastasis |
| Q39540154 | Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells. |
| Q38985389 | Control of NF-kB activity in human melanoma by bromodomain and extra-terminal protein inhibitor I-BET151. |
| Q60958246 | Cytokines, Chemokines, and Other Biomarkers of Response for Checkpoint Inhibitor Therapy in Skin Cancer |
| Q42575715 | Decoding melanoma metastasis |
| Q38944200 | Elevated chronic inflammatory factors and myeloid-derived suppressor cells indicate poor prognosis in advanced melanoma patients |
| Q38965216 | Fisetin and Its Role in Chronic Diseases. |
| Q36638192 | Host immunity contributes to the anti-melanoma activity of BRAF inhibitors |
| Q39111312 | IL-18 regulates melanoma VLA-4 integrin activation through a Hierarchized sequence of inflammatory factors |
| Q36520732 | IRF-8 controls melanoma progression by regulating the cross talk between cancer and immune cells within the tumor microenvironment. |
| Q39172114 | Immunotargeting and eradication of orthotopic melanoma using a chemokine-enhanced DNA vaccine |
| Q39799151 | Inflammation and tumor microenvironment in lymph node metastasis |
| Q34346108 | Interleukin-8 in breast cancer progression |
| Q35100014 | Intracellular coexpression of CXC- and CC- chemokine receptors and their ligands in human melanoma cell lines and dynamic variations after xenotransplantation. |
| Q90344037 | Keratinocyte cadherin desmoglein 1 controls melanocyte behavior through paracrine signaling |
| Q38994985 | Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment |
| Q41388747 | Mechanisms of CXCR7 induction in malignant melanoma development |
| Q42281809 | Mechanistic insights into molecular evolution of species-specific differential glycosaminoglycan binding surfaces in growth-related oncogene chemokines. |
| Q34096529 | Melanocyte and melanoma cell activation by calprotectin. |
| Q90043581 | Melanoma Metabolism: Cell Survival and Resistance to Therapy |
| Q36738000 | Melanoma-derived conditioned media efficiently induce the differentiation of monocytes to macrophages that display a highly invasive gene signature |
| Q36823360 | Microsomal PGE2 synthase-1 regulates melanoma cell survival and associates with melanoma disease progression |
| Q38043052 | Mitophagy or how to control the Jekyll and Hyde embedded in mitochondrial metabolism: implications for melanoma progression and drug resistance |
| Q38092784 | Molecular biology of normal melanocytes and melanoma cells |
| Q36552658 | NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug |
| Q36782461 | Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b |
| Q37641748 | PADI4 has genetic susceptibility to gastric carcinoma and upregulates CXCR2, KRT14 and TNF-α expression levels |
| Q38549236 | Perspective of Targeting Cancer-Associated Fibroblasts in Melanoma |
| Q36711023 | Phorbol ester-induced neutrophilic inflammatory responses selectively promote metastatic spread of melanoma in a TLR4-dependent manner |
| Q36905877 | Prognostic molecular biomarkers for cutaneous malignant melanoma |
| Q28538588 | Retinoid-X-receptors (α/β) in melanocytes modulate innate immune responses and differentially regulate cell survival following UV irradiation |
| Q35770942 | Role of chemokine receptor CXCR2 expression in mammary tumor growth, angiogenesis and metastasis. |
| Q34367591 | Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases |
| Q42017582 | Soluble MHC-peptide complexes: tools for the monitoring of T cell responses in clinical trials and basic research. |
| Q60928165 | TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness |
| Q28276026 | Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma |
| Q59128386 | The Role of Melanoma Cell-Stroma Interaction in Cell Motility, Invasion, and Metastasis |
| Q37970636 | The Tumor-Promoting Flow of Cells Into, Within and Out of the Tumor Site: Regulation by the Inflammatory Axis of TNFα and Chemokines |
| Q37373366 | The tumor microenvironment: the making of a paradigm |
| Q38005015 | Tissue-specific homing of immune cells in malignant skin tumors. |
| Q41892254 | Tumor-promoting circuits that regulate a cancer-related chemokine cluster: dominance of inflammatory mediators over oncogenic alterations |
| Q35358884 | Vascular dysfunction and increased metastasis of B16F10 melanomas in Shb deficient mice as compared with their wild type counterparts. |
| Q36011319 | Vinyl sulfone analogs of lysophosphatidylcholine irreversibly inhibit autotaxin and prevent angiogenesis in melanoma |
| Q39054278 | Xmrk-induced melanoma progression is affected by Sdf1 signals through Cxcr7. |
Search more.